Registro:

Referencias:

• Rosendaal, F.R., Venous thrombosis: A multicausal disease (1999) Lancet, 353, pp. 1167-1173
• Guba, S.C., Fonseca, V., Fink, L.M., Hyperhomocysteinemia and thrombosis (1999) Semin Thromb Hemost, 25, pp. 291-309
• Ueland, M., Homocysteine species as components of plasma redox thiol status (1995) Clin Chem, 41, pp. 340-342
• Rozen, R., Genetic modulation of homocysteinemia (2000) Semin Thromb Hemost, 26, pp. 255-261
• Frosst, P., Blom, H.J., Milos, R., Goyette, P., Sheppard, C.A., Matthews, R.G., A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase (1995) Nat Genet, 10, pp. 111-113
• Schneede, J., Refsum, H., Ueland, P.M., Biological and environmental determinants of plasma homocysteine (2000) Semin Thromb Hemost, 26, pp. 263-279
• Lahiri, D.K., Nurnberger, J.I., A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies (1991) Nucleic Acids Res, 19, p. 5444
• Bertina, R.M., Koeleman, B.P., Koster, T., Rosendaal, F.R., Dirven, R.J., de Ronde, H., Mutation in blood coagulation factor V associated with resistance to activated protein C (1994) Nature, 369, pp. 64-67
• Poort, S.R., Rosendaal, F.R., Reitsma, P.H., Berina, R.M., A common genetic variation in the 3′ untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis (1996) Blood, 88, pp. 3698-3703
• McCully, K.S., Vascular pathology of homocysteinaemia: Implications for the pathogenesis of arteriosclerosis.Am (1969) J Pathol, 56, pp. 111-128
• Graham, I.M., Daly, L.E., Refsum, H.M., Robinson, K., Brattstrom, L.E., Ueland, P.M., Plasma homocysteine as a risk factor for vascular disease: The European Concerted Action Project (1997) J Am Med Assoc, 277, pp. 1775-1781
• Herrmann, W., The importance of hyperhomocysteinemia as a risk factor for diseases: An overview (2001) Clin Chem Lab Med, 39, pp. 666-674
• Refsum, H., Nurk, E., Smith, A.D., Ueland, P.M., Gjesdal, C.G., Bjelland, I., The Hordaland Homocysteine study: A community-based study of homocysteine, its determinants, and associations with disease (2006) J Nutr, 136, pp. 1731-1740
• Ueland, P.M., Refsum, H., Stabler, S., Malinow, M.R., Andersson, A., Allen, R.H., Total homocysteine in plasma or serum: Methods and clinical applications (1993) Clin Chem, 39, pp. 1764-1779
• Selhub, J., Jacques, P.F., Rosenberg, I.H., Rogers, G., Bowman, B.A., Gunter, E.W., Serum total homocysteine concentrations in the Third National Health and Nutrition Examination Survey (1991-1994): Population reference ranges and contribution of vitamin status to high serum concentration (1999) Ann Intern Med, 131, pp. 331-339
• Rasmussen, K., Moller, J., Lyngbak, M., Pedersen, A., Dybkjaer, L., Age- and gender-specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation (1996) Clin Chem, 42, pp. 630-636
• Ubbink, J., Becker, P., Hayward Vermaak, W.J., Delport, R., Results of B-vitamin supplementation study used in a prediction model to define a reference range for plasma homocysteine (1995) Clin Chem, 41, pp. 1033-1037
• Fokkema, M.R., Weijer, J.M., Dijck-Brouwer, D.A., van Doormaal, J.J., Muskiet, F.A., Influence of vitamin-optimized plasma homocysteine cutoff values on the prevalence of hyperhomocysteinemia in healthy adults (2001) Clin Chem, 47, pp. 1001-1007
• Refsum, H., Smith, A.D., Ueland, P.M., Nexo, E., Clarke, R., McPartlin, J., Facts and recommendations about total homocysteine determinations: An expert opinion (2004) Clin Chem, 50, pp. 3-32
• Den Heijer, M., Lewington, S., Clarke, R., Homocysteine, MTHFR and risk of venous thrombosis: A meta-analysis of published epidemiological studies (2005) J Thromb Haemost, 3, pp. 292-299
• Oger, E., Lacut, K., Le Gal, G., Couturaud, F., Guenet, D., Abalain, J.H., Hyperhomocysteinemia and low B vitamin levels are independently associated with venous thromboembolism: Results from the EDITH study: a hospitalbased case-control study (2006) J Thromb Haemost, 4, pp. 793-799
• Quere, I., Gris, J.C., Dauzat, M., Homocysteine and venous thrombosis (2005) Semin Vasc Med, 5, pp. 183-189
• Obeid, R., Hakki, T., Jouma, M., Herrmann, W., The risk of venous thromboembolism associated with the factor V Leiden mutation and low B-vitamin status (2003) Clin Chem Lab Med, 41, pp. 1357-1362
• Keijzer, M.B., den Heijer, M., Blom, H.J., Bos, G.M., Willems, H.P., Gerrits, W.B., Interaction between hyperhomocysteinemia, mutated methylene-tetrahydrofolate reductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis (2002) Thromb Haemost, 88, pp. 723-728
• den Heijer, M., Koster, T., Henk, J., Blom, H.J., Bos, G.M., Briët, E., Hyperhomocysteinemia as a risk factor for deepvein thrombosis (1996) N Engl J Med, 334, pp. 759-762
• Arruda, V.R., von Zuben, P.M., Chiaparini, L.C., Annichino-Bizzacchi, J.M., Costa, F.F., The mutation Ala677 → Val in the methylene tetrahydrofolate reductase gene: A risk factor for arterial disease and venous thrombosis (1997) Thromb Haemost, 77, pp. 818-821
• Margaglione, M., D'Andrea, G., d'Addedda, M., Giuliani, N., Cappucci, G., Iannaccone, L., The methylene-tetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A 20210 mutation (1998) Thromb Haemost, 79, pp. 907-911
• Ray, J.G., Shmorgun, D., Chan, W.S., Common C677T polymorphism of the methylene-tetrahydrofolate reductase gene and the risk of venous thromboembolism: Metaanalysis of 31 studies (2002) Pathophysiol Haemost Thromb, 32, pp. 51-58
• Tsai, A.W., Cushman, M., Tsai, M.Y., Heckbert, S.R., Rosamond, W.D., Aleksic, N., Serum homocysteine, thermolabile variant of methylene tetrahydrofolate reductase (MTHFR), and venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology (LITE) (2003) Am J Hematol, 72, pp. 192-200

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------